Novel reaction to new cystic fibrosis medication Trikafta.

Stashower, Julian; Carr, Patrick; Miller, Virginia; Zlotoff, Barrett

Stashower, Julian; Carr, Patrick; Miller, Virginia; Zlotoff, Barrett.

Afiliação

Stashower J; University of Virginia School of Medicine Charlottesville VA USA.
Carr P; Department of Dermatology University of Virginia School of Medicine Charlottesville VA USA.
Miller V; Department of Pathology University of Virginia School of Medicine Charlottesville VA USA.
Zlotoff B; Departments of Dermatology and Pediatrics Pediatric Dermatology University of Virginia School of Medicine Charlottesville VA USA.

Clin Case Rep ; 9(5): e04116, 2021 May.

Article em En | MEDLINE | ID: mdl-34026156

ABSTRACT

ABSTRACT

We present a novel case of an urticaria multiforme-type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.

Palavras-chave

Trikafta; cystic fibrosis; drug rash; urticaria; urticaria multiforme

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links